120 related articles for article (PubMed ID: 3428947)
21. Combination therapy of the H2712 murine mammary carcinoma with cytotoxic T lymphocytes and anti-estrogens.
Baral E; Nagy E; Kangas L; Berczi I
Anticancer Res; 1997; 17(5A):3647-51. PubMed ID: 9413217
[TBL] [Abstract][Full Text] [Related]
22. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
Stutman O
Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
[TBL] [Abstract][Full Text] [Related]
23. Extraction of a murine tumor-specific antigen from cells and plasma membranes using 1-butanol: augmentation of antigen yield by colchicine.
LeGrue SJ; Kahan BD
Cancer Res; 1985 May; 45(5):1926-9. PubMed ID: 4039219
[TBL] [Abstract][Full Text] [Related]
24. Purification of antigens of mammary tumor of the mouse by gel filtration.
Laing CA; Japal KM
Biochem Med Metab Biol; 1986 Dec; 36(3):340-6. PubMed ID: 3026423
[TBL] [Abstract][Full Text] [Related]
25. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
[TBL] [Abstract][Full Text] [Related]
26. Characterization of n-butyl alcohol solubilized, breast tumor specific antigens recognized by a human autologous cytotoxic T-cell clone.
Sato T; Sato N; Takahashi S; Okubo M; Yagihashi A; Torigoe T; Takahashi N; Okazaki M; Asaishi K; Kukuchi K
Cancer Res; 1988 Jul; 48(14):3892-7. PubMed ID: 3260127
[TBL] [Abstract][Full Text] [Related]
27. Tube leukocyte adherence-inhibition response to related and unrelated tumor antigens in mammary tumor-bearing mice.
Chattopadhyay U; Guha S
Tumori; 1983 Aug; 69(4):299-303. PubMed ID: 6623652
[TBL] [Abstract][Full Text] [Related]
28. Leukocyte adherence inhibition: an automated microassay demonstrating specific antigen recognition and blocking activity in two murine tumor systems.
Leveson SH; Howell JH; Holyoke ED; Goldrosen MH
J Immunol Methods; 1977; 17(1-2):153-62. PubMed ID: 71330
[TBL] [Abstract][Full Text] [Related]
29. In vitro immune responses to viral and tumor antigens in murine breast cancer.
Sigel MM; Lopez DM; Ortiz-Muniz G
Cancer Res; 1976 Feb; 36(2 pt 2):748-52. PubMed ID: 1253159
[TBL] [Abstract][Full Text] [Related]
30. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
Black MM; Zachrau RE
J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of B6RV2 leukemia growth by immunization with purified unique antigen.
Uenaka A; Nakayama E
Jpn J Cancer Res; 1992 Jun; 83(6):650-5. PubMed ID: 1644667
[TBL] [Abstract][Full Text] [Related]
32. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
[TBL] [Abstract][Full Text] [Related]
33. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
Elliott BE; Carlow DA; Ivimey L; Arnold M; Hampton N; Bosman P
Cancer Res; 1987 Sep; 47(18):4915-23. PubMed ID: 2441856
[TBL] [Abstract][Full Text] [Related]
34. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
Rios A; Simmons RL
Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
[TBL] [Abstract][Full Text] [Related]
35. Cellular immunity to the mammary tumour virus in mice bearing primary mammary tumours.
Creemers P; Bentvelzen P
Eur J Cancer (1965); 1977 Jun; 13(6):503-10. PubMed ID: 69543
[No Abstract] [Full Text] [Related]
36. Extraction of a murine tumor-specific transplantation antigen with 1-butanol. I. Partial purification by isoelectric focusing.
LeGrue SJ; Kahan BD; Pellis NR
J Natl Cancer Inst; 1980 Jul; 65(1):191-6. PubMed ID: 6930513
[TBL] [Abstract][Full Text] [Related]
37. A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma.
Bakács T; Lee J; Moreno MB; Zacharchuk CM; Cole MS; Tso JY; Paik CH; Ward JM; Segal DM
Int Immunol; 1995 Jun; 7(6):947-55. PubMed ID: 7577803
[TBL] [Abstract][Full Text] [Related]
38. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
[TBL] [Abstract][Full Text] [Related]
39. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
Ritzi EM; Smith BA; Stolfi RL; Martin DS
Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
